Largest pharmaceutical companies in the United States by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 44 pharmaceutical companies in the United States ranked by total liabilities, at THB 4.65T, ahead of Pfizer (THB 4.11T) and Johnson & Johnson (THB 3.99T). Figures as of 20 Nov 2026, 08:49 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- AbbVieTHB 4.65T
- Median
- THB 28.2B
- Combined market value
- THB 126.61T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | THB 4.65T | THB 16.99T | THB 9,609.17 | 0.86% down | 25% up | ||
| 2 | PfizerPFE · Health Care | THB 4.11T | THB 5.32T | THB 933.33 | 1.85% down | 15% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | THB 3.99T | THB 21.79T | THB 9,053.37 | 2.04% down | 34% up | ||
| 4 | Eli LillyLLY · Health Care | THB 2.91T | THB 40.79T | THB 45,789.46 | 2.29% down | 33% up | ||
| 5 | Merck & CoMRK · Health Care | THB 2.85T | THB 11.1T | THB 4,500.93 | 3.61% down | 45% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | THB 2.42T | THB 4.04T | THB 1,977.14 | 2.05% down | 30% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | THB 1.15T | THB 6.1T | THB 3,520.15 | 0.58% down | 16% down | ||
| 8 | ViatrisVTRS · Health Care | THB 761.9B | THB 772.4B | THB 673.73 | 1.97% down | 99% up | ||
| 9 | ZoetisZTS · Health Care | THB 411.3B | THB 1.11T | THB 2,737.97 | 5.59% down | 26% down | ||
| 10 | Royalty PharmaRPRX · Health Care | THB 335.7B | THB 1.32T | THB 2,295.03 | 1.38% down | 79% up | ||
| 11 | Regeneron PharmaceuticalsREGN · Health Care | THB 315.2B | THB 3.24T | THB 31,291.99 | 2.35% down | 28% up | ||
| 12 | Vertex PharmaceuticalsVRTX · Health Care | THB 236.5B | THB 4.47T | THB 17,645.17 | 2.94% down | 27% up | ||
| 13 | Elanco Animal HealthELAN · Health Care | THB 230.8B | THB 445.3B | THB 890.97 | 1.54% down | 26% up | ||
| 14 | Alnylam PharmaceuticalsALNY · Health Care | THB 141.6B | THB 671B | THB 5,009.62 | 1.06% down | 66% down | ||
| 15 | Amneal PharmaceuticalsAMRX · Health Care | THB 124.5B | THB 252.6B | THB 724.91 | 2.24% down | 90% up | ||
| 16 | PTC TherapeuticsPTCT · Health Care | THB 105.2B | THB 165.1B | THB 1,976.63 | 3.16% down | 21% down | ||
| 17 | Ionis PharmaceuticalsIONS · Health Care | THB 102.8B | THB 153.6B | THB 922.49 | 0.62% down | 63% down | ||
| 18 | BridgeBio PharmaBBIO · Health Care | THB 102.1B | THB 516.1B | THB 2,649.52 | 0.22% up | 21% up | ||
| 19 | CytokineticsCYTK · Health Care | THB 70.6B | THB 242.9B | THB 1,743.98 | 0.27% up | 19% down | ||
| 20 | InsmedINSM · Health Care | THB 51.7B | THB 1.07T | THB 4,895.75 | 20.58% up | 40% down | ||
| 21 | BioMarin PharmaceuticalBMRN · Health Care | THB 51.1B | THB 403.2B | THB 2,081.52 | 0.02% down | 17% up | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | THB 29.9B | THB 209.1B | THB 1,479.30 | 1.25% up | 13% up | ||
| 23 | United TherapeuticsUTHR · Health Care | THB 26.6B | THB 807B | THB 18,947.90 | 3.16% down | 22% up | ||
| 24 | Legend BiotechLEGN · Health Care | THB 24.8B | THB 105.8B | THB 545.63 | 0.92% down | 41% down | ||
| 25 | Madrigal PharmaceuticalsMDGL · Health Care | THB 22.3B | THB 312.3B | THB 13,445.52 | 0.34% down | 27% down | ||
| 26 | Axsome TherapeuticsAXSM · Health Care | THB 20.4B | THB 241.9B | THB 4,598.20 | 1.25% up | 6% down | ||
| 27 | Ligand PharmaceuticalsLGND · Health Care | THB 18.4B | THB 194.5B | THB 9,724.40 | 3.94% down | 50% up | ||
| 28 | Mirum PharmaceuticalsMIRM · Health Care | THB 17.9B | THB 211.3B | THB 3,236.83 | 3.27% up | 34% up | ||
| 29 | Travere TherapeuticsTVTX · Health Care | THB 16.6B | THB 157.1B | THB 1,636.89 | 3.86% down | 45% up | ||
| 30 | TG TherapeuticsTGTX · Health Care | THB 14.1B | THB 332.3B | THB 2,198.78 | 1.88% down | 117% up | ||
| 31 | Cogent BiosciencesCOGT · Health Care | THB 10.2B | THB 163.6B | THB 940.11 | 0.25% down | 20% down | ||
| 32 | Rhythm PharmaceuticalsRYTM · Health Care | THB 7.1B | THB 274.4B | THB 3,958.35 | 1.88% down | 18% up | ||
| 33 | Corcept TherapeuticsCORT · Health Care | THB 6.4B | THB 241B | THB 2,202.17 | 4.15% down | 10% down | ||
| 34 | Definium TherapeuticsDFTX · Health Care | THB 3.7B | THB 136.8B | THB 999.08 | 1.24% up | 168% up | ||
| 35 | Summit TherapeuticsSMMT · Health Care | THB 3.1B | THB 286.5B | THB 358.22 | 0.67% up | 36% down | ||
| 36 | ErascaERAS · Health Care | THB 2.4B | THB 169.1B | THB 481.92 | 3.34% up | 395% up | ||
| 37 | Spyre TherapeuticsSYRE · Health Care | THB 2.1B | THB 314.2B | THB 3,308.68 | 3.77% down | 332% up | ||
| 38 | Praxis Precision MedicinesPRAX · Health Care | THB 2B | THB 294.5B | THB 10,536.40 | 1.87% up | 86% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | THB 1.8B | THB 274.3B | THB 4,203.04 | 2.47% down | 51% up | ||
| 40 | Dianthus TherapeuticsDNTH · Health Care | THB 1.3B | THB 161.9B | THB 2,874.89 | 1.01% up | 108% up | ||
| 41 | Edgewise TherapeuticsEWTX · Health Care | THB 1B | THB 152.8B | THB 1,395.25 | 0.48% down | 86% up | ||
| 42 | Oruka TherapeuticsORKA · Health Care | THB 565.5M | THB 224.3B | THB 3,306.65 | 1.91% up | 255% up | ||
| 43 | Belite BioBLTE · Health Care | THB 341.3M | THB 207.9B | THB 5,118.07 | 3.33% down | 43% up | ||
| 44 | VeradermicsMANE · Health Care | THB 310.3M | THB 177.9B | THB 4,215.58 | 0.38% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 33.8900 THB).
Questions and answers
Which pharmaceutical companies in the United States rank first by total liabilities?
AbbVie (THB 4.65T), Pfizer (THB 4.11T) and Johnson & Johnson (THB 3.99T) are the top three of the 44 pharmaceutical companies in the United States ranked by total liabilities as of 20 Nov 2026, 08:49 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by total liabilities.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by total liabilities have a combined market value of THB 126.61T as of 20 Nov 2026, 08:49 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total liabilities”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.